Related Experiment Videos

Recurrent acute encephalopathy due to fatty acid metabolic defect--report of two cases

C H Chen1, C C Chi, N Y Shu

  • 1National Yang-Ming Medical College, Taichung, Taiwan, R.O.C.

Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|April 1, 1991
PubMed

Insights

Inherited metabolic diseases can mimic Reye's syndrome in infants. Fatty acid metabolism defects should be considered in children presenting with recurrent Reye-like symptoms, especially with hyperammonemia.

Area of Science:

  • Biochemistry
  • Pediatric Medicine
  • Genetics

Background:

  • Reye's syndrome is a rare but serious condition.
  • Some inherited metabolic diseases can present with symptoms similar to Reye's syndrome.

Purpose of the Study:

  • To describe two cases of Reye-like syndrome in infants.
  • To highlight the potential role of inherited metabolic diseases, specifically fatty acid metabolism defects, in the etiology of Reye-like syndrome.

Main Methods:

  • Case report of two infants presenting with Reye-like syndrome.
  • Clinical evaluation including blood tests (lactate, ammonia, glucose), liver function tests.
  • Biopsies of liver and muscle for histopathological examination, including electron microscopy of liver mitochondria.

Main Results:

  • Both patients developed Reye-like syndrome at 7 months of age, with symptoms including conscious disturbance, hepatomegaly, impaired liver function, hyperammonemia, and nonketotic hypoglycemia.
  • Blood lactate levels were normal; liver and muscle biopsies showed macrovesicular fatty change.
  • Mitochondrial abnormalities were observed in liver cells (increased matrix density in patient 1, stacked cristae in patient 2).
  • Recurrent episodes of hyperammonemia and Reye-like symptoms were noted in both patients throughout infancy and early childhood.

Conclusions:

  • Fatty acid metabolic defects should be strongly considered in the differential diagnosis of infants and children presenting with recurrent Reye-like syndrome.
  • Early diagnosis and intervention are crucial for managing these metabolic disorders and preventing severe outcomes.

Related Concept Videos